High Genetic Stability of the Region Coding for the Structural Proteins of Yellow Fever Virus Strain 17D

References

1. Auperin D., Sasso D. R., McCormick J. B. 1986; Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA. Virology 154:155–167
   [Google Scholar]
2. Grange T., Bouloy M., Girard M. 1985; Stable secondary structures at the 3ʹ-end of the genome of yellow fever virus (17D vaccine strain). FEBS Letters 188:159–163
   [Google Scholar]
3. Gubler U., Hoffman B. J. 1983; A simple and very efficient method for generating cDNA libraries. Gene 25:263–269
   [Google Scholar]
4. Holland J., Spindler K., Horodyski F., Grabau E., Nichol S., Van De Pol S. 1982; Rapid evolution of RNA genomes. Science 215:1577–1585
   [Google Scholar]
5. Liprandi F. 1981; Isolation of plaque variants differing in virulence from the 17D strain of yellow fever virus. Journal of General Virology 56:363–370
   [Google Scholar]
6. Monath T. P., Kinney R. M., Schlesinger J. I., Brandriss M. W., Brès P. 1983; Ontogeny of yellow fever 17D vaccine: RNA oligonucleotide fingerprint and monoclonal antibody analyses of vaccines produced worldwide. Journal of General Virology 64:627–637
   [Google Scholar]
7. Okayama H., Berg P. 1982; High efficiency cloning of full-length cDNA. Molecular and Cellular Biology 2:161–170
   [Google Scholar]
8. Rice C. M., Lenches E. M., Eddy S. R., Shin S. J., Sheets R. I., Strauss J. H. 1985; Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229:726–733
   [Google Scholar]
9. Sanger F., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain termination inhibitors. Proceedings of the National Academy of Sciences U.S.A.: 745463–5467
   [Google Scholar]
10. World Health Organization 1979 Procedure for WHO Approval of Yellow Fever Vaccine for Issue of International Vaccination Certificates Report of a WHO Working Group; Geneva:22–24May 1979
    [Google Scholar]